Splitting Brain Radiosurgery into Three to Five Sessions After Tumor Removal Lowered Recurrence in 242-Patient Trial
Splitting Brain Radiosurgery into Three to Five Sessions After Tumor Removal Lowered Recurrence in 242-Patient Trial Medical Daily
Splitting Brain Radiosurgery into Three to Five Sessions After Tumor Removal Lowered Recurrence in 242-Patient Trial Medical Daily
In a study published in Cancer Discovery, cancer neoantigens and neoantigen-specific T cells were identified from patient blood samples by analyzing circulating tumor DNA (ctDNA) and immune cells.
Алдонин снова покинул Россию и отправился на лечение от рака: «Казалось, все складывается неплохо, но увы…» Sport24.ru
Создание «врачей», выписывание пациентов, излеченных от опухолей, и последующая продажа «традиционной вьетнамской медицины»: мошенническая схема, нацеленная на пациентов в интернете. Vietnam.vn
CHICAGO — Women working as physicians should not wait to be asked to take on leadership positions at their practices, according to a presenter at the Women in Medicine Summit. “I was just a regular old, middle-of-the-pack person for most of my life,” Christine DeSanno, DO, chief of service in the department of…
«Он настоящий мужик и боец»: Булыкин рассказал о ежедневной борьбе Алдонина с раком RuNews24
Drs. Steven Dubinett from UCLA and Lecia Sequist from Mass General/Harvard Receive Inaugural 2026 Research Awards for Transformative Work in Early Lung Cancer Detection PR Newswire
Cleveland Clinic London Appoints Dr Heather Shaw as Oncology Vice Chief Cleveland Clinic Newsroom
Research into rare breast cancer type highlights importance of personalised treatment The Institute of Cancer Research
Upping Your Exercise Game in Cancer Care Medscape
Первый симптом этого вида рака легко принять за инфекцию и дотянуть до последней стадии Doctorpiter
Собака ударила хозяина в пах и случайно помогла ему узнать, что он умирает от рака почки Life.ru
AstraZeneca takes $2bn stake in cancer-drug maker Summit Therapeutics The Times
В Казахстане прошла международная конференция по современной онкологии Новости Zakon.kz
FDA Approves Teva’s DEGEVMA Biosimilar to Xgeva for Cancer Bone Complications The Clinical Trial Vanguard